Qualicaps at CPhI Worldwide on 5-7 November
Qualicaps will be appearing at CPhI Worldwide on 5-7 November. CPhI Worldwide is the world's...
Inhalation delivery offers significant and unique benefits in the treatment of a variety of illnesses.
The lungs serve as a portal of entry to the body that enables a drug to infiltrate the bloodstream from the airways in a time-effective manner, presenting inhaled formulations as an interesting alternative to oral dosage forms, especially when a rapid response is required.
Originally developed for respiratory diseases, DPIs have seen their use expanded recently to a growing field of therapies, including antibiotics, insulin, opioids, oxytocin, vaccines, and drugs for neurological disorders.
Qualicaps will be appearing at CPhI Worldwide on 5-7 November. CPhI Worldwide is the world's...
Genix has announced that it will now be known as Qualicaps. Acquired at the end of...
Qualicaps has announced it will be attending CPhI. For nearly 30 years, CPhI has organised...
Join Qualicaps at the Javits Center in New York City for INTERPHEX. The company will...